These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 951433)

  • 1. Differential actions of d- and 1-amphetamine on the metabolism of 3H-norepinephrine in rat brain.
    Peterson DW; Sparber SB
    Pharmacol Biochem Behav; 1976 May; 4(5):545-9. PubMed ID: 951433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of 3H-dopamine continuously perfused through push-pull cannulas in rats' brains: modification by amphetamine or prostaglandin F2 alpha.
    Nielsen JA; Fossom LH; Sparber SB
    Pharmacol Biochem Behav; 1980 Aug; 13(2):235-42. PubMed ID: 7413695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclazocine and norepinephrine uptake, metabolism, and turnover in the rat brain.
    Russi GD
    J Pharm Sci; 1985 Jan; 74(1):97-9. PubMed ID: 3981430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
    Calderini G; Morselli PL; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the effects of prostaglandins and d-amphetamine on the metabolism of 3H-dopamine continuously presented to rat brain in vivo.
    Nielsen JA; Sparber SB
    Pharmacol Biochem Behav; 1984 Oct; 21(4):583-9. PubMed ID: 6095323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D- and l-amphetamine differentially mediates self-stimulation in rat dorsal midbrain area.
    Ellman SJ; Ackermann RF; Bodnar RJ; Jackler F; Steiner SS
    Physiol Behav; 1976 Jan; 16(1):1-7. PubMed ID: 1273106
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of cathinone and amphetamine on fixed-interval operant responding: a rate-dependency analysis.
    Goudie AJ
    Pharmacol Biochem Behav; 1985 Sep; 23(3):355-65. PubMed ID: 4048231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain.
    Taylor KM; Snyder SH
    Brain Res; 1971 May; 28(2):295-309. PubMed ID: 5113521
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):103-17. PubMed ID: 619124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of norepinephrine and normetanephrine from cat brain by central nervous system stimulants.
    Carr LA; Moore KE
    Biochem Pharmacol; 1970 Sep; 19(9):2671-5. PubMed ID: 4394597
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin potentiates the operant behavior suppressant and rectal temperature lowering effects of low doses of d-amphetamine in rats.
    Nielsen JA; Sparber SB
    Pharmacol Biochem Behav; 1984 Aug; 21(2):219-24. PubMed ID: 6483934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine elevations in cerebrospinal fluid after d- and l-amphetamine.
    Ziegler MG; Lake CR; Ebert MH
    Eur J Pharmacol; 1979 Aug; 57(2-3):127-33. PubMed ID: 114399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.